LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Anglo up - Read More
LONDON (Alliance News) - Nuformix PLC on Friday said it has begun clinical studies for its anti-nausea drug NXP001 and dosed its first patient.Shares in Nuformix were down 4.6% at 2.10 on a Read More
LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC on Monday reported positive results from its completed NXP002 fibrosis programme pre-clinical trial for the treatment of a of Read More
LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC said on Tuesday it has expanded its current licensing agreement with partner Newsummit Biopharma for the development of cancer Read More
LONDON (Alliance News) - Shares in pharmaceutical firm Nuformix PLC rose Friday it has received a GBP500,000 payment after its NXP001 product reached a pre-clinical milestone.Nuformix was a Read More
LONDON (Alliance News) - Nuformix PLC on Thursday posted a sharply widened annual loss due to its reverse takeover of Nuformix Technologies Ltd.Shares in Nuformix were down 10% at 2.60 on a Read More
LONDON (Alliance News) - Pharmaceutical company Nuformix PLC said Friday that it has appointed Christopher Blackwell, the former chief executive officer of Vectura Group PLC, as non-executive of a Read More